Sun Nuclear Corporation Research Articles

Implementation of an ionization chamber array for linear accelerator monthly dosimetry QA.

The IC Profiler (ICP) manufactured by Sun Nuclear Corporation (SNC) is an ionization chamber (IC) array used for linear accelerator dosimetry measurements. Previous work characterized response of the ICP under various conditions, but there is limited work of its implementation into monthly QA measurement procedures. This work quantifies ICP accuracy and variables that affect accuracy for beam output measurements, and demonstrates feasibility of using the ICP for all recommended monthly dosimetry measurements. A total of 1985 output measurements on six Varian TrueBeam and Edge linear accelerators were performed using three ICP with quad wedges (QWs) and were compared with conventional IC measurements. The accuracy of the ICP for beam output was characterized as the difference between the ICP and IC. Variables that affect ICP accuracy, including gain settings, calibrations, and template baselining as well as machine or energy-specific bias were investigated. Measurements of profile constancy, energy, dose rate constancy, wedge factors, and gating were performed. The initially observed mean output difference between the ICP and IC was 0.16% (0.61%). When gain settings were optimized, the output difference accuracy improved to -0.02% (0.38%). The output accuracy of the ICP was not dependent on array, dose, temperature and pressure calibrations, or template baselining. Statistically, ICP output accuracy was dependent on machine and beam energy, but clinically, all measurements fell within 0.5% of unity. ICP measurements of energy, dose rate constancy, and wedge factors matched passing results with conventional IC in water measurements. Gating and beam profile constancy measurements demonstrated good stability using the ICP. Finally, monthly dosimetry QA using ICP was completed in an average of 33 min compared to 66 min using the IC. This work demonstrated the feasibility and efficiency of using the ICP, with specific considerations, as a measurement device for dosimetric linear accelerator monthly QA.

Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030

The demand for radiotherapy in Brazil is unfulfilled, and the scarcity of data on the national network hampers the development of effective policies. We aimed to evaluate the current situation, estimate demands and requirements, and provide an action plan to ensure access to radiotherapy for those in need by 2030. The Brazilian Society for Radiation Oncology created a task force (RT2030) including physicians, medical physicists, policy makers, patient advocates, and suppliers, all of whom were major stakeholders involved in Brazilian radiotherapy care. The group was further divided into seven working groups to address themes associated with radiotherapy care in Brazil. From March 1, 2019, to Aug 3, 2020, there were monthly meetings between the group's leaders and the Central Committee and six general meetings. First, a comprehensive search of all different national databases was done to identify all radiotherapy centres. Questionnaires evaluating radiotherapy infrastructure and human resources and assing the availability, distribution, capacity, and workload of resources were created and sent to the radioprotection supervisor of each centre. Results were analysed nationally and across the country's regions and health-care systems. A pre-planned review of available databases was done to gather data on active radiation oncology centres and the distribution of radiotherapy machines (linear accelerators [LINACs]) across Brazil. We used national population and cancer incidence projections, recommended radiotherapy usage from the medical literature, and national working patterns to project radiotherapy demands in 2030. An action plan was established with suggestions to address the gaps and meet the demands. The database search yielded 279 centres with an active radiotherapy registry. After applying predefined exclusion criteria, 263 centres were identified that provided external beam radiotherapy machines with or without brachytherapy. All 263 operational centres answered the questionnaires sent on Dec 9, 2019, which were then returned between Jan 1 and June 30, 2020. There were 409 therapy machines, 646 radiation oncologists, 533 physicists, and 230 989 patients undergoing radiotherapy (150 628 [65·2%] in the public health-care system and 80 937 [35·0%] in private). The mean annual occupation rate was 566 patients per treatment machine (SD 250). The number of residents per treatment machine ranged from 258 333 to 1 800 000. Technology availability varied considerably among regions and systems. In 2030, 639 994 new cancer cases are expected, which will require 332 797 radiotherapy courses. Therefore, 530 LINACs, 1079 radiation oncologists, and 1060 medical physicists will be needed. The expected increase in cancer incidence in the coming years will probably increase the disparities in cancer care and the burden for Brazilian patients. We provide a roadmap of the current situation and the particularities of the Brazilian radiotherapy network, which can serve as a starting point for cancer policy planning to improve this scenario. Accuray, BRAINLAB, Elekta, IBA, ONE medical solution, SUN NUCLEAR corporation, VARIAN, and ZIGMA.

A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot study.

The Medical Physics Working Group of the Radiation Therapy Study Group at the Japan Clinical Oncology Group is currently developing a virtual audit system for intensity-modulated radiation therapy dosimetry credentialing. The target dosimeters include films and array detectors, such as ArcCHECK (Sun Nuclear Corporation, Melbourne, Florida, USA) and Delta4 (ScandiDos, Uppsala, Sweden). This pilot study investigated the feasibility of our virtual audit system using previously acquired data. We analyzed 46 films (32 and 14 in the axial and coronal planes, respectively) from 29 institutions. Global gamma analysis between measured and planned dose distributions used the following settings: 3%/3mm criteria (the dose denominator was 2Gy), 30% threshold dose, no scaling of the datasets, and 90% tolerance level. In addition, 21 datasets from nine institutions were obtained for array evaluation. Five institutions used ArcCHECK, while the others used Delta4. Global gamma analysis was performed with 3%/2mm criteria (the dose denominator was the maximum calculated dose), 10% threshold dose, and 95% tolerance level. The film calibration and gamma analysis were conducted with in-house software developed using Python (version 3.9.2). The means±standard deviations of the gamma passing rates were 99.4±1.5% (range, 92.8%-100%) and 99.2±1.0% (range, 97.0%-100%) in the film and array evaluations, respectively. This pilot study demonstrated the feasibility of virtual audits. The proposed virtual audit system will contribute to more efficient, cheaper, and more rapid trial credentialing than on-site and postal audits; however, the limitations should be considered when operating our virtual audit system.

The first mobile photon-counting detector CT: the human images and technical performance study

Objective. The purpose of this study is to assess its human images and its unique capabilities such as the ‘on demand’ higher spatial resolution and multi-spectral imaging of photon-counting-detector (PCD)-CT. Approach. In this study, the FDA 510(k) cleared mobile PCD-CT (OmniTom Elite) was used. To this end, we imaged internationally certified CT phantoms and a human cadaver head to evaluate the feasibility of high resolution (HR) and multi-energy imaging. We also demonstrate the performance of PCD-CT via first-in-human imaging by scanning three human volunteers. Main results. At the 5 mm slice thickness, routinely used in diagnostic head CT, the first human PCD-CT images were diagnostically equivalent to the EID-CT scanner. The HR acquisition mode of PCD-CT achieved a resolution of 11 line-pairs (lp)/cm as compared to 7 lp cm−1 using the same kernel (posterior fossa-kernel) in the standard acquisition mode of EID-CT. For the quantitative multi-energy CT performance, the measured CT numbers in virtual mono-energetic images (VMI) of iodine inserts in the Gammex Multi-Energy CT phantom (model 1492, Sun Nuclear Corporation, USA) matched the manufacturer reference values with mean percent error of 3.25%. Multi-energy decomposition with PCD-CT demonstrated the separation and quantification of iodine, calcium, and water. Significance. PCD-CT can achieve multi-resolution acquisition modes without physically changing the CT detector. It can provide superior spatial resolution compared with the standard acquisition mode the conventional mobile EID-CT. Quantitative spectral capability of PCD-CT can provide accurate, simultaneous multi-energy images for material decomposition and VMI generation using a single exposure.

Online adaptive radiotherapy and dose delivery accuracy: A retrospective analysis.

With online adaptive radiotherapy (ART), patient-specific quality assurance (PSQA) testing cannot be performed prior to delivery of the adapted treatment plan. Consequently, the dose delivery accuracy of adapted plans (i.e., the ability of the system to interpret and deliver the treatment as planned) are not initially verified. We investigated the variation in dose delivery accuracy of ART on the MRIdian 0.35T MR-linac (Viewray Inc., Oakwood, USA) between initial plans and their respective adapted plans, by analyzing PSQA results. We considered the two main digestive localizations treated with ART (liver and pancreas). A total of 124 PSQA results acquired with the ArcCHECK (Sun Nuclear Corporation, Melbourne, USA) multidetector system were analyzed. PSQA result variations between the initial plans and their respective adapted plans were statistically investigated and compared with the variation in MU number. For the liver, limited deterioration in PSQA results was observed, and was within the limits of clinical tolerance (Initial=98.2%, Adapted=98.2%, p=0.4503). For pancreas plans, only a few significant deteriorations extending beyond the limits of clinical tolerance were observed and were due to specific, complex anatomical configurations (Initial=97.3%, Adapted=96.5%, p=0.0721). In parallel, we observed an influence of the increase in MU number on the PSQA results. We show that the dose delivery accuracy of adapted plans, in terms of PSQA results, is preserved in ART processes on the 0.35T MR-linac. Respecting good practices, and minimizing the increase in MU number can help to preserve the accuracy of delivery of adapted plans as compared to their respective initial plans.

A novel Monte Carlo (MC) dose model for small MLC fields of the cyberknife® M6TM radiosurgery system using the EGSnrc.

The multi-leaf collimator (MLC)-equipped CyberKnife® M6 radiosurgery system (CKM6) (Accuray Inc., Sunnyvale, CA) has been increasingly employed for stereotactic radiosurgery (SRS) to treat relatively small lesions. However, achieving an accurate dose distribution in such cases is usually challenging due to the combination of numerous small fields≤(30×30)mm2 . In this study, we developed a new Monte Carlo (MC) dose model for the CKM6 system using the EGSnrc to investigate dose variations in the small fields. The dose model was verified for the static MLC fields ranging from (53.8×53.9) to (7.6×7.7) mm2 at 800mm source to axis distance in a water phantom, based on the computed doses of Accuray Precision® (Accuray Inc.) treatment planning system (TPS). We achieved a statistical uncertainty of ≤4% by simulating 30-50 million incident particles/histories. Then, the treatment plans were created for the same fields in the TPS, and the corresponding measurements were performed with MapCHECK2 (Sun Nuclear Corporation), a standard device for patient-specific quality assurance (PSQA). Results of the MC simulations, TPS, and MapCHECK2 measurements were inter-compared. An overall difference in dosimetric parameters such as profiles, tissue maximum ratio (TMR), and output factors (OF) between the MC simulations and the TPS results was found ≤3% for (53.8×53.9-15.4×15.4) mm2 MLC fields, and it rose to 4.5% for the smallest (7.6mm×7.7mm) MLC field. The MapCHECK2 results showed a deviation ranging from -1.5% to + 4.5% compared to the TPS results, whereas the deviation was within±2.5% compared with the MC results. Overall, our MC dose model for the CKM6 system showed better agreement with measurements and it could serve as a secondary dose verification tool for the patient-specific QA in small fields.

Dosimetric evaluation of a treatment planning system using the AAPM Medical Physics Practice Guideline 5.a (MPPG 5.a) validation tests.

Verifying the accuracy of the dose calculation algorithm is considered one of the most critical steps in radiotherapy treatment for delivering an accurate dose to the patient. This work aimed to evaluate the dosimetric performance of the treatment planning system (TPS) algorithms; the AAA (v. 15.6), AXB (v. 15.6) and eMC (v. 15.6) following the AAPM medical physics practice guideline 5.a (MPPG 5.a) validation tests package in a Varian iX Linear Accelerator (Linac). A series of tests were developed based on the MPPG 5.a. on a Varian's Eclipse TPS (v. 15.6) (Varian Medical Systems). First, the basic photon and electron tests were validated by comparing the TPS calculated dose with the measurements. Next, for heterogeneity tests, we verified the Computed Tomography number to electron density (CT-to-ED) curve by comparing it with the baseline values, and TPS calculated point doses beyond heterogeneous media were compared to the measurements. Finally, for IMRT/VMAT dose validation tests, clinical reference plans were re-calculated on ArcCheck's virtual phantom (Sun Nuclear Corporation, Melbourne, FL, USA) and exported to the Linac for delivery using the ArcCheck dosimetry system. All validation tests were evaluated following the MPPG 5.a recommended tolerances. In basic dose validation tests, the TPS calculated depth dose profiles agreed well with the measurements, with a minimum gamma passing rate of 95% at 2%/2mm criteria. However, disagreements are seen in the build-up and penumbra region. Results for most point doses in homogeneous water phantoms were within the MPPG 5.a tolerance. For the heterogeneity tests, the CT-to-ED curve was established, and calculated point doses were all within 3% of the measurements for heterogeneous media for both photon algorithms at three energies. These results are within the MPPG5.a the recommended tolerance of 3%. Moreover, for electron beams, the differences between the calculated and measured point doses averaged 5% and 7%, but were just within the MPPG 5.a tolerance of 7%. For IMRT and VMAT validation tests using a gamma criteria of a 2%/2mm, IMRT plans showed maximum and minimum passing rates of 98.2% and 97.4%, respectively. Whereas VMAT plans showed maximum and minimum passing rates of 100% and 94.3%, respectively. We conclude that the dosimetric accuracy of the Eclipse TPS (v15.6) algorithm is adequate for clinical use. The MPPG 5.a tests are valuable for evaluating dose calculation accuracy and are very useful for TPS upgrade checks, commissioning tests, and routine TPS QA.

Comparison of MLC positioning deviations using log files and establishment of specific assessment parameters for different accelerators with IMRT and VMAT

Background and purposeThe study evaluated the differences in leaf positioning deviations by the log files of three advanced accelerators with two delivery techniques, and established specific assessment parameters of leaf positioning deviations for different types of accelerators.MethodsA total of 420 treatment plans with 5 consecutive treatment log files were collected from the Trilogy, TrueBeam and Halcyon accelerators. Millennium MLC was equipped on the Trilogy and TrueBeam accelerators. A jawless design and dual-layer MLC were adopted on the Halcyon accelerator. 70 IMRT and 70 VMAT plans were selected randomly on each accelerator. The treatment sites of all plans included head and neck, chest, breast, pelvis and other sites. The parsing tasks for 2100 log files were proceeded by SunCheck software from Sun Nuclear Corporation. The maximum leaf root mean square (RMS) errors, 95th percentile errors and percentages of different leaf positioning errors were statistically analyzed. The correlations between these evaluation parameters and accelerator performance parameters (maximum leaf speed, mean leaf speed, gantry and arc angle) were analyzed.ResultsThe average maximum leaf RMS errors of the Trilogy in the IMRT and VMAT plans were 0.44 ± 0.09 mm and 0.79 ± 0.07 mm, respectively, which were higher than the TrueBeam's 0.03 ± 0.01 mm, 0.03 ± 0.01 mm and the Halcyon's 0.05 ± 0.01 mm, 0.07 ± 0.01 mm. Similar data results were shown in the 95th percentile error. The maximum leaf RMS errors were strongly correlated with the 95th percentile errors (Pearson index > 0.5). The leaf positioning deviations in VMAT were higher than those in IMRT for all accelerators. In TrueBeam and Halcyon, leaf position errors above 1 mm were not found in IMRT and VMAT plans. The main influencing factor of leaf positioning deviation was the leaf speed, which has no strong correlation with gantry and arc angles.ConclusionsCompared with the quality assurance guidelines, the MLC positioning deviations tolerances of the three accelerators should be tightened. For both IMRT and VMAT techniques, the 95th percentile error and the maximum RMS error are suggested to be tightened to 1.5 and 1 mm respectively for the Trilogy accelerator. In TrueBeam and Halcyon accelerators, the 95th percentile error and maximum RMS error of 1 and 0.5 mm, respectively, are considered appropriate.

Detection of rotational errors in single-isocenter multiple-target radiosurgery: Is a routine off-axis Winston-Lutz test necessary?

PurposeRecently the use of linear accelerator (linac)‐based stereotactic radiosurgery (SRS) has increased, including single‐isocenter multiple‐target SRS. The workload of medical physicists has grown as a result and so has the necessity of maximizing the efficiency of quality assurance (QA). This study aimed to determine if measurement‐based patient‐specific QA with a high‐spatial‐resolution dosimeter is sensitive to rotational errors, potentially reducing the need for routine off‐axis Winston–Lutz (WL) testing.MethodsThe impact of rotational errors along gantry, couch, and collimator axes on dose coverage of the gross tumor volume (GTV) and planning target volume (PTV) was determined with a 1‐mm GTV/PTV expansion margin. Two techniques, the off‐axis WL test using the StereoPHAN MultiMet‐WL Cube (Sun Nuclear Corporation, Melbourne, Florida, USA) and patient‐specific QA using the SRS MapCHECK (Sun Nuclear Corporation, Melbourne, Florida, USA), were assessed on their ability to detect introduced errors before target coverage was compromised. These findings were also considered in the context of routine machine QA of rotational axis calibrations.ResultsRotational errors significantly impacted PTV dose coverage, especially in the couch angle. GTV dose coverage remained unaffected except for with large couch angle errors (≥1.5°). The off‐axis WL test was shown to be sensitive to rotational errors with results consistently exceeding tolerance levels when or before coverage fell below departmentally accepted limits. Although patient‐specific QA using the SRS MapCHECK was previously validated for SRS, this study showed inconsistency in detection of rotational errors.ConclusionsIt is recommended that off‐axis WL testing be conducted regularly to supplement routine monthly machine QA, as it is sensitive to errors that patient‐specific QA may not detect. This frequency should be determined by individual departments, with consideration of GTV–PTV margins used, limitations on target off‐axis distances, and routine mechanical QA results for particular linacs.

Monte Carlo calculated beam quality correction factors for two cylindrical ionization chambers in photon beams.

Although several studies provide data for reference dosimetry, the SNC600c and SNC125c ionization chambers (Sun Nuclear Corporation, Melbourne, FL) are in clinical use worldwide for which no beam quality correction factors kQ are available. The goal of this study was to calculate beam quality correction factors kQ for these ionization chambers according to dosimetry protocols TG-51, TRS 398 and DIN 6800-2. Monte Carlo simulations using EGSnrc have been performed to calculate the absorbed dose to water and the dose to air within the active volume of ionization chamber models. Both spectra and simulations of beam transport through linear accelerator head models were used as radiation sources for the Monte Carlo calculations. kQ values as a function of the respective beam quality specifier Q were fitted against recommended equations for photon beam dosimetry in the range of 4 MV to 25 MV. The fitting curves through the calculated values showed a root mean square deviation between 0.0010 and 0.0017. The investigated ionization chamber models (SNC600c, SNC125c) are not included in above mentioned dosimetry protocols, but are in clinical use worldwide. This study covered this knowledge gap and compared the calculated results with published kQ values for similar ionization chambers. Agreements with published data were observed in the 95% confidence interval, confirming the use of data for similar ionization chambers, when there are no kQ values available for a given ionization chamber.

Virtual monoenergetic images from dual-energy CT: systematic assessment of task-based image quality performance.

To compare task-based image quality (TB-IQ) among virtual monoenergetic images (VMI) and linear-blended images (LBI) from dual-energy CT as a function of contrast task, radiation dose, size, and lesion diameter. A TB-IQ phantom (Mercury Phantom 4.0, Sun Nuclear Corporation) was imaged on a third-generation dual-source dual-energy CT with 100/Sn150 kVp at three volume CT dose levels (5, 10, 15 mGy). Three size sections (diameters 16, 26, 36 cm) with subsections for image noise and spatial resolution analysis were used. High-contrast tasks (e.g., calcium-containing stone and vascular lesion) were emulated using bone and iodine inserts. A low-contrast task (e.g., low-contrast lesion or hematoma) was emulated using a polystyrene insert. VMI at 40-190 keV and LBI were reconstructed. Noise power spectrum (NPS) determined the noise magnitude and texture. Spatial resolution was assessed using the task-transfer function (TTF) of the three inserts. The detectability index (d') served as TB-IQ metric. Noise magnitude increased with increasing phantom size, decreasing dose, and decreasing VMI-energy. Overall, noise magnitude was higher for VMI at 40-60 keV compared to LBI (range of noise increase, 3-124%). Blotchier noise texture was found for low and high VMIs (40-60 keV, 130-190 keV) compared to LBI. No difference in spatial resolution was observed for high contrast tasks. d' increased with increasing dose level or lesion diameter and decreasing size. For high-contrast tasks, d' was higher at 40-80 keV and lower at high VMIs. For the low-contrast task, d' was higher for VMI at 70-90 keV and lower at 40-60 keV. Task-based image quality differed among VMI-energy and LBI dependent on the contrast task, dose level, phantom size, and lesion diameter. Image quality could be optimized by tailoring VMI-energy to the contrast task. Considering the clinical relevance of iodine, VMIs at 50-60 keV could be proposed as an alternative to LBI.

Evaluating the Impact of Ionization Chamber-Specific Beam Quality Correction Factor in Dosimetry of Filtered and Unfiltered Photon Beams.

Aim:The response of ionization chamber changes when used at beam quality Q which is different from beam quality Qo (usually 60Co) that was used at the time of its calibration. Hence, one needs to apply beam quality correction factor (kQ, Qo) during dosimetric measurements. However, kQ, Qo data are unavailable for novel ion chambers in the literature. Moreover, most of such data do not differentiate between filtered (flat) and unfiltered (unflat) beams. In addition, literature-based data do not differentiate among different pieces of the ion chambers of the same make and model. Hence, the purpose of our study was to determine the ion chamber-specific experimental values of kQ, Qo and to evaluate their impact in dosimetry.Materials and Methods:In this work, the value of kQ, Qo were measured for six ionization chambers of three different types in 6, 10, and 15 MV filtered (with flattening filter [WFF]) as well as 6 and 10 MV unfiltered (flattening filter free [FFF]) photon beams. The measured values of kQ, Qo were compared with Monte Carlo-calculated values available in the literature. The uncertainties in measurement of kQ, Qo values were also evaluated.Results:For 6 MV FFF beam, the measured value of kQ, Qo was found to be consistently lower than 6 MV WFF beam for all Sun Nuclear Corporation ion chambers, while it was higher as per the theoretical data. The inter-chamber variation in kQ, Qo values was observed for the same model of the ion chambers. The maximum difference between absolute dose values on using the theoretical and experimental kQ, Qo values was up to 3.23%.Conclusion:The measured absolute dose values by the ion chamber of a given make and model were found different due to the use of its theoretical and experimental kQ, Qo values. Furthermore, the variation in response of different pieces of ion chambers of the same make and model cannot be accounted for theoretically, and hence, the use of theoretical kQ, Qo data may introduce an inherent error in the estimation of absorbed dose to water. This necessitates the use of measured value of kQ, Qo for each ionization chamber.

Technical Note: Long-term monitoring of diode sensitivity degradation induced by proton irradiation.

To measure diode sensitivity degradation (DSD) induced by cumulative proton dose delivered to a commercial daily quality assurance (QA) device. At our institution, six Daily QA 3 (DQA3, Sun Nuclear Corporation, Melbourne, FL, USA) devices have been used for daily proton pencil beam scanning QA in four proton gantry rooms over a span of 4 years. DQA3 diode counts were cross-calibrated using a homogenous field with a known dose of 1Gy. The DSD rate (ΔR%/100Gy) was calculated using linear regression on time-series plots of diode counts and an estimate of cumulative dose per year based on the cross-calibration. The effect of DSD on daily QA spot position measurements was quantified by converting DSD to baseline spot position shift. The average dose delivered to the four inner DQA3 diodes was 104±5Gy/year, and the rate of DSD was -5.1%±1.0/100Gy with the exception of one DQA3 device that had a significantly higher rate of DSD (-12%/100Gy). The R2 s of the linear fit to time-series plots were between 0.92 and 0.98. The DSD rates were not constant but decreases with accumulated doses. The four center diodes, which received 40% of the cumulative dose received by inner diodes, had a DSD rate of -7.2%±0.9/100Gy. For our daily QA program, 1 year of DSD was equivalent to a 0.2mm shift in spot position. The DSD rate of DQA3 diodes determined by long-term proton daily QA data was about -5%/100Gy, which is more than 10 times greater than the reported DSD rate from photon irradiation. DQA3 diodes may be used for daily proton QA programs, provided that they are recalibrated at an appropriate frequency that should be determined specifically for different daily QA programs.

Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy.

Purposes: To evaluate whether the auto-planning (AP) module can achieve clinically acceptable treatment plans for lung stereotactic body radiotherapy (SBRT) and to evaluate the effectiveness of a dose prediction model.Methods: Twenty lung SBRT cases planned manually with 50 Gy in five fractions were replanned using the Pinnacle (Philips Radiation Oncology Systems, Fitchburg, WI) AP module according to the dose constraint tables from the Radiation Therapy Oncology Group (RTOG) 0813 protocol. Doses to the organs at risk (OAR) were compared between the manual and AP plans. Using a dose prediction model from a commercial product, PlanIQ (Sun Nuclear Corporation, Melbourne, FL), we also compared OAR doses from AP plans with predicted doses.Results: All manual and AP plans achieved clinically required dose coverage to the target volumes. The AP plans achieved equal or better OAR sparing when compared to the manual plans, most noticeable in the maximum doses of the spinal cord, ipsilateral brachial plexus, esophagus, and trachea. Predicted doses to the heart, esophagus, and trachea were highly correlated with the doses of these OARs from the AP plans with the highest correlation coefficient of 0.911, 0.823, and 0.803, respectively.Conclusion: Auto-planning for lung SBRT improved OAR sparing while keeping the same dose coverage to the tumor. The dose prediction model can provide useful planning dose guidance.

Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms.

PurposeTo compare radiotherapy plans between an O‐ring and a conventional C‐arm linac for hypofractionated high‐dose prostate radiotherapy in terms of plan quality, dose distribution, and quality assurance in a multi‐vendor environment.MethodsTwenty prostate cancer treatment plans were irradiated on the O‐ring Varian Halcyon linac and were re‐optimized for the C‐arm Elekta Synergy Agility linac. Dose‐volume histogram metrics for target coverage and organ at risk dose, quality assurance, and monitor units were retrospectively compared. Patient‐specific quality assurance with ion chamber measurements, gamma index analysis, and portal dosimetry was performed using the Varian Portal Dosimetry system and the ArcCHECK® phantom (Sun Nuclear Corporation). Prostate‐only radiotherapy was delivered with simultaneous integrated boost (SIB) volumetric modulated arc therapy (VMAT) in 20 fractions of 2.5/3.0 Gy each.ResultsFor both linacs, target coverage was excellent and plan quality comparable. Homogeneity in PTVBoost was high for Synergy as well as Halcyon with a mean homogeneity index of 0.07 ± 0.01 and 0.05 ± 0.01, respectively. Mean dose for the organs at risk rectum and bladder differed not significantly between the linacs but were higher for the femoral heads and penile bulb for Halcyon. Quality assurance showed no significant differences in terms of ArcCHECK gamma pass rates. Median pass rate for 3%/2 mm was 99.3% (96.7 to 99.8%) for Synergy and 99.8% (95.6 to 100%) for Halcyon. Agreement between calculated and measured dose was high with a median deviation of −0.6% (−1.7 to 0.8%) for Synergy and 0.2% (−0.6 to 2.3%) for Halcyon. Monitor units were higher for the Halcyon by approximately 20% (p < 0.001).ConclusionHypofractionated high‐dose prostate cancer SIB VMAT on the Halcyon system is feasible with comparable plan quality in reference to a standard C‐arm Elekta Synergy linac.

PO06: Evaluation of an Electrometer for Use with High Dose Rate Brachytherapy

Purpose: The PC Electrometer (PCE) is a small, portable, electrometer that interfaces with a computer via USB cable and is manufactured by Sun Nuclear Corporation (Melbourne, FL). It is marketed as a ‘reference class’ electrometer but is primarily marketed and targeted for external beam applications with a focus on beam calibration and scanning. This study aims to evaluate use of the PCE for high dose-rate (HDR) Ir-192 brachytherapy applications.

Improving dose delivery accuracy with EPID in vivo dosimetry: results from amulticenter study.

To investigate critical aspects and effectiveness of in vivo dosimetry (IVD) tests obtained by an electronic portal imaging device (EPID) in amulticenter and multisystem context. Eight centers with three commercial systems-SoftDiso (SD, Best Medical Italy, Chianciano, Italy), Dosimetry Check (DC, Math Resolution, LCC), and PerFRACTION (PF,Sun Nuclear Corporation, SNC, Melbourne, FL)-collected IVD results for atotal of 2002 patients and 32,276 tests. Data are summarized for IVD software, radiotherapy technique, and anatomical site. Every center reported the number of patients and tests analyzed, and the percentage of tests outside of the tolerance level (OTL%). OTL% was categorized as being due to incorrect patient setup, incorrect use of immobilization devices, incorrect dose computation, anatomical variations, and unknown causes. The three systems use different approaches and customized alert indices, based on local protocols. For Volumetric Modulated Arc Therapy (VMAT) treatments OTL% mean values were up to 8.9% for SD, 18.0% for DC, and 16.0% for PF. Errors due to "anatomical variations" for head and neck were up to 9.0% for SD and DC and 8.0% for PF systems, while for abdomen and pelvis/prostate treatments were up to 9%, 17.0%, and 9.0% for SD, DC, and PF, respectively. The comparison among techniques gave 3% for Stereotactic Body Radiation Therapy, 7.0% (range 4.7-8.9%) for VMAT, 10.4% (range 7.0-12.2%) for Intensity Modulated Radiation Therapy, and 13.2% (range 8.8-21.0%) for 3D Conformal Radiation Therapy. The results obtained with different IVD software and among centers were consistent and showed an acceptable homogeneity. EPID IVD was effective in intercepting important errors.

Radon variability due to floor level in two typical residential buildings in Serbia

Abstract It is well known that one of the factors that influence the indoor radon variability is the floor level of the buildings. Considering the fact that the main source of indoor radon is radon in soil gas, it is expected that the radon concentration decreases at higher floors. Thus at higher floors the dominant source of radon is originating from building materials, and in some cases there may be deviations from the generally established regularity. In such sense, we chose one freestanding single-family house with loft and other 16-floor high-rise residential building for this study. The indoor radon measurements were performed by two methods: passive and active. We used passive devices based on track-etched detectors: Radtrak2 Radonova. For the short-term indoor radon measurements, we used two active devices: SN1029 and SN1030 (manufactured by Sun Nuclear Corporation). The first device was fixed in the living room at the ground level and the second was moved through the floors of the residential building. Every measuring cycle at the specified floor lasted seven days with the sampling time of 2 h. The results show two different indoor radon behaviours regarding radon variability due to floor level. In the single-family house with loft we registered intense difference between radon concentration in the ground level and loft, while in the high-rise residential building the radon level was almost the same at all floors, and hence we may conclude that radon originated mainly from building materials.

The effect of the horizontal metallic drive on reference dosimetry in the SNC 3D scanner water tank.

Accurate quantification of absorbed radiation dose is important for safe and effective delivery of radiation therapy. An important aspect to this is reference dosimetry, which is performed under reference conditions specified by international codes of practice. Such measurements are usually performed in a water phantom. In the Sun Nuclear Corporation (SNC) three‐dimensional (3D) scanner water tank system the detector holder is fixed to a horizontal metallic drive rail (MDR) which is in close proximity to the active volume of the detector. In this project, the dosimetric effects of the MDR on reference dosimetry were investigated for MV photons, MeV electrons, and kV photons by comparing reference dosimetry measurements in the SNC 3D scanner against similar measurements in a Standard Imaging (SI) one‐dimensional (1D) tank and against measurements in the SNC 3D scanner with an additional, custom‐made spacer placed beneath the chamber holder to increase the chamber ‐ MDR separation. A second experiment investigated the difference in chamber reading dependent on chamber to MDR separation by fixing the chamber in the tank independently of the MDR and successively moving the MDR vertically to alter the separation. The results showed that measurements in the SNC 3D scanner agree with both SI 1D tank and SNC 3D scanner with spacer to within ±0.3% for MV photons, ±0.1% for electrons and ±1.2% for kV photons within the calculated setup uncertainty. The second experiment showed that the contribution of backscatter from the MDR was significant if the distance between MDR and chamber was reduced below the chamber's designed position in the SNC 3D scanner. The exception was for kV photons where the contribution of backscatter from the MDR was measured to be 0.5% at the designed distance. Further investigation would be useful for kV photons, where the experiment showed relatively large measurement uncertainties.

Technical Note: Dosimetric characterization of the dynamic beam flattening MLC sequence on a ring shaped, Jawless Linear Accelerator with double stacked MLC.

To characterize the dosimetric features and limitations of the dynamic beam flattening (DBF) on the Halcyon 2.0 linear accelerator (Varian Medical Systems). A predefined multi-leaf collimator (MLC) sequence was introduced and used to flatten the 6MV flattening filter free (FFF) beam on the Halcyon 2.0. Dosimetric characterizations of the flattened beams, including beam flatness, symmetry, percent depth dose (PDD), output factor and MU linearity, were investigated. Flatness and symmetry were obtained from profile measurements with both radiographic films (EDR2) and a two dimensional ion-chamber array (IC Profiler, Sun Nuclear Corporation). MU linearity, output factors, and PDDs were measured in a water tank with a CC13 ion chamber (Scanditronix Wellhöfer, Nuremburg, Germany). In addition, the effect of the DBF sequence on 3D plan quality was evaluated by creating DBF plans for a 4-field box rectum and an AP/PA spine plan. Patient specific QA was performed on these plans. At 100cm SSD and 10cm depth, a flatness of <3% was observed on both transversal and radial profiles for all square field sizes ≥10cm with DBF. For both larger and smaller field sizes the flatness showed a tendency to increase as the fields got bigger or smaller, respectively. Similar trends in flatness were observed at all depths measured. All measured output factors for square field sizes ≥5cm were within 1% of the TPS prediction. Linearity was ≤2.02% for all measurements. For both treatment sites, the MD judged the plans created for the Halcyon without the use of DBF not to be clinically acceptable, however considered both the TrueBeam plan and the Halcyon plan with the DBF sequence to be clinically acceptable. The DBF sequence on the Halcyon and its characteristics were investigated. The analysis indicates that the DBF sequence can be used on the Halcyon to generate clinically acceptable 3D treatment plans.